Literature DB >> 17925161

Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.

Michael A Moskowitz1.   

Abstract

Migraine headaches have a complex pathophysiology; both vascular and neuronal mechanisms have been proposed. One possible scenario begins with a series of destabilising events within the brain that trigger cortical spreading depression (CSD). CSD can cause both migraine aura and trigeminal activation which, in turn, promotes neuropeptide release and triggers peripheral and central mechanisms that promote headache and autonomic activation. Susceptibility to CSD and to migraine is, in part, genetically determined. The best evidence to date comes from certain subtypes of migraine with aura in which point mutations in genes controlling translocation of calcium, sodium and potassium have been implicated. This review briefly summarises recent migraine research that supports CSD as an upstream driver of the migraine attack as well as an activator of the trigemino-vascular system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925161

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  15 in total

Review 1.  Identification of molecular genetic factors that influence migraine.

Authors:  Bridget H Maher; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2011-04-26       Impact factor: 3.291

Review 2.  The pathophysiology of brain swelling associated with subdural hemorrhage: the role of the trigeminovascular system.

Authors:  Waney Squier; Julie Mack; Alex Green; Tipu Aziz
Journal:  Childs Nerv Syst       Date:  2012-08-11       Impact factor: 1.475

Review 3.  Migraine and cardiovascular disease: possible mechanisms of interaction.

Authors:  M E Bigal; T Kurth; H Hu; N Santanello; R B Lipton
Journal:  Neurology       Date:  2009-05-26       Impact factor: 9.910

Review 4.  Migraine and epilepsy: a focus on overlapping clinical, pathophysiological, molecular, and therapeutic aspects.

Authors:  Marino Muxfeldt Bianchin; Renata Gomes Londero; José Eduardo Lima; Marcelo Eduardo Bigal
Journal:  Curr Pain Headache Rep       Date:  2010-08

Review 5.  Antidepressants in long-term migraine prevention.

Authors:  Horst J Koch; Tim P Jürgens
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case-control study.

Authors:  Alfred N Fonteh; Janice M Pogoda; Rainbow Chung; Robert P Cowan; Michael G Harrington
Journal:  J Headache Pain       Date:  2013-07-04       Impact factor: 7.277

7.  Migraine, cerebrovascular disease and the metabolic syndrome.

Authors:  Alexandra J Sinclair; Manjit Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

8.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

Review 9.  Contributions of Ca2+ and Zn2+ to spreading depression-like events and neuronal injury.

Authors:  Robert M Dietz; John H Weiss; C William Shuttleworth
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

10.  Current migraine management - patient acceptability and future approaches.

Authors:  Arnaud Fumal; Jean Schoenen
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.